Han‐Fei Ding

7.5k total citations · 2 hit papers
131 papers, 5.6k citations indexed

About

Han‐Fei Ding is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Han‐Fei Ding has authored 131 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Molecular Biology, 28 papers in Cancer Research and 22 papers in Neurology. Recurrent topics in Han‐Fei Ding's work include Neuroblastoma Research and Treatments (22 papers), Cancer-related Molecular Pathways (15 papers) and Epigenetics and DNA Methylation (15 papers). Han‐Fei Ding is often cited by papers focused on Neuroblastoma Research and Treatments (22 papers), Cancer-related Molecular Pathways (15 papers) and Epigenetics and DNA Methylation (15 papers). Han‐Fei Ding collaborates with scholars based in China, United States and Georgia. Han‐Fei Ding's co-authors include Zheng Dong, David E. Fisher, Hongjuan Cui, Shuang Huang, Chunhong Yan, Jane Ding, Gaël McGill, Junran Zhang, Tai Li and Hongbo Wang and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Han‐Fei Ding

122 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ATF3 promotes erastin-induced ferroptosis by suppressing system Xc–

2019 611 citations Han‐Fei Ding, Chunhong Yan et al. profile →
Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability

2002 578 citations Han‐Fei Ding, David E. Fisher et al. profile →

Peers

Countries citing papers authored by Han‐Fei Ding

Since Specialization

Citations

This map shows the geographic impact of Han‐Fei Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han‐Fei Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han‐Fei Ding more than expected).

Fields of papers citing papers by Han‐Fei Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han‐Fei Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han‐Fei Ding. The network helps show where Han‐Fei Ding may publish in the future.

Co-authorship network of co-authors of Han‐Fei Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Han‐Fei Ding. A scholar is included among the top collaborators of Han‐Fei Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han‐Fei Ding. Han‐Fei Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DKC1-mediated pseudouridylation of rRNA targets hnRNP A1 to sustain IRES-dependent translation and ATF4-driven metabolic adaptation 2025 ·Science Advances ·(unknown), Mohit Bansal, (unknown), Suman Karki, (unknown), Sunil Sudarshan, Han‐Fei Ding	2
2	HDAC7 promotes renal cancer progression by reprogramming branched-chain amino acid metabolism 2025 ·Science Advances ·Hyeyoung Nam, Anirban Kundu, Suman Karki, Richard Kirkman, Darshan S. Chandrashekar, Jeremy B. Foote, Guofang Zhang, (unknown), Sooryanarayana Varambally, Han‐Fei Ding, Sunil Sudarshan	0
3	Bio-inspired multimodal soft grippers: a review 2025 ·Bioinspiration & Biomimetics ·Liang Meng, Jiaqi Zhu, Xingxing Ke, (unknown), Han‐Fei Ding, Zhigang Wu	0
4	An AI‐Enabled All‐In‐One Visual, Proximity, and Tactile Perception Multimodal Sensor 2025 ·(unknown), (unknown), (unknown), Chaoqun Han, (unknown), (unknown), Han‐Fei Ding, Zhigang Wu	1
5	A unified framework for dynamic parameter identification of elastic joint robots with hysteresis and friction nonlinearities 2025 ·Mechanical Systems and Signal Processing ·Jiexin Zhang, Huan Zhao, (unknown), (unknown), (unknown), Honghai Liu, Han‐Fei Ding	0
6	Identification and validation of UBE2B as a prognostic biomarker promoting the development of esophageal carcinomas 2024 ·Frontiers in Immunology ·Han‐Fei Ding, Jiacheng Xu, Zhiguo Ding, Linfeng Wu, Yanbo Liu, Yifei Zhang, (unknown), Yiqun Zhang, Ping‐Hong Zhou	1
7	Novel carbon dots with dual Modulatory effects on the bone marrow and spleen as a potential therapeutic candidate for treating spinal cord injury 2024 ·Bioactive Materials ·Junjin Li, Hongda Wang, (unknown), (unknown), (unknown), (unknown), Yilin Pang, Jie Ren, (unknown), Enjun Gao, (unknown), (unknown), P. P. Zhao, Han‐Fei Ding, Baoyou Fan, (unknown), (unknown), Zhijian Wei, Guangzhi Ning, Yongqiang Li, Shiqing Feng	3
8	Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity 2023 ·JCI Insight ·Siyao Li, Man J. Livingston, (unknown), Xiaoru Hu, Lu Wen, Han‐Fei Ding, Daohong Zhou, Zheng Dong	60
9	Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma 2023 ·Cancer Research ·Gia‐Buu Tran, (unknown), Bingwei Ye, (unknown), Yajie Yu, Yunhong Zha, Zheng Dong, Kebin Liu, Sunil Sudarshan, Han‐Fei Ding	8
10	An Individually Controlled Multitined Expandable Electrode Using Active Cannula‐Based Shape Morphing for On‐Demand Conformal Radiofrequency Ablation Lesions 2022 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Xianwen Chen, Jiaqi Zhu, Huageng Liang, Han‐Fei Ding, Zhigang Wu	4
11	DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma 2022 ·JCI Insight ·Thale Kristin Olsen, Cecilia Dyberg, (unknown), (unknown), Jelena Milosevic, Jane Ding, Jörg Otte, (unknown), Ida Hed Myrberg, Ellen M. Westerhout, Jan Köster, Rogier Versteeg, Han‐Fei Ding, Per Kogner, John Inge Johnsen, David B. Sykes, Ninib Baryawno	21
12	JQ-1 ameliorates schistosomiasis liver granuloma in mice by suppressing male and female reproductive systems and egg development of Schistosoma japonicum 2022 ·PLoS neglected tropical diseases ·Jiaming Tian, (unknown), (unknown), (unknown), Han‐Fei Ding, (unknown), (unknown), Cuiping Ren, Jijia Shen, (unknown)	1
13	Therapeutic targeting of both dihydroorotate dehydrogenase and nucleoside transport in MYCN-amplified neuroblastoma 2021 ·Cell Death and Disease ·Yajie Yu, Jane Ding, Shunqin Zhu, Ahmet Alptekin, Zheng Dong, Chunhong Yan, Yunhong Zha, Han‐Fei Ding	22
14	Metabolic Reprogramming by MYCN Confers Dependence on the Serine-Glycine-One-Carbon Biosynthetic Pathway 2019 ·Cancer Research ·Yingfeng Xia, Bingwei Ye, Jane Ding, Yajie Yu, Ahmet Alptekin, Muthusamy Thangaraju, Puttur D. Prasad, Zhi-Chun Ding, Eun Jeong Park, Jeong‐Hyeon Choi, Bei Gao, Oliver Fiehn, Chunhong Yan, Zheng Dong, Yunhong Zha, Han‐Fei Ding	77
15	Bif-1 Interacts with Prohibitin-2 to Regulate Mitochondrial Inner Membrane during Cell Stress and Apoptosis 2019 ·PMC ·(unknown), Xiao Xiao, Shixuan Wang, Hua Gao, Ruslan Rafikov, Stephen M. Black, (unknown), Han‐Fei Ding, Yisang Yoon, Robert A. Kirken, Xiao‐Ming Yin, Hong‐Gang Wang, Zheng Dong	1
16	Histone demethylase KDM6B has an anti-tumorigenic function in neuroblastoma by promoting differentiation 2019 ·Oncogenesis ·Liqun Yang, Yunhong Zha, Jane Ding, Bingwei Ye, Mengling Liu, Chunhong Yan, Zheng Dong, Hongjuan Cui, Han‐Fei Ding	29
17	Triple negative breast cancer development can be selectively suppressed by sustaining an elevated level of cellular cyclic AMP through simultaneously blocking its efflux and decomposition 2016 ·Oncotarget ·Wei Wang, Yue Li, Jessica Zhu, Dongdong Fang, Han‐Fei Ding, Zheng Dong, Qing Jing, Shi-Bing Su, Shuang Huang	20
18	HOXC9 directly regulates distinct sets of genes to coordinate diverse cellular processes during neuronal differentiation 2013 ·BMC Genomics ·Xiangwei Wang, Jeong-Hyeon Choi, Jane Ding, Liqun Yang, Lambert Ngoka, Eun Jig Lee, Yunhong Zha, Ling Mao, Bilian Jin, Mingqiang Ren, John K. Cowell, Shuang Huang, Huidong Shi, Hongjuan Cui, Han‐Fei Ding	22
19	HOXC9 Links Cell-Cycle Exit and Neuronal Differentiation and Is a Prognostic Marker in Neuroblastoma 2011 ·Cancer Research ·Ling Mao, Jane Ding, Yunhong Zha, Liqun Yang, Brian A. McCarthy, William C. King, Hongjuan Cui, Han‐Fei Ding	58
20	Induction of apoptosis in cancer: new therapeutic opportunities 2002 ·Annals of Medicine ·Han‐Fei Ding, David E. Fisher	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact